The reduced release of GH by GHRH in 8 subjects aged 65-69 years is augmented considerably by rivastigmine, a drug for Alzheimer's disease.

Abstract

BACKGROUND The growth hormone (GH) secretion declines by 14% with each decade of adult life. Several attempts have been made to reverse the manifestations of the senile GH deficiency, termed somatopause, but GH substitution treatment in old age has not yet developed an established regimen. Cholinesterase inhibitors like pyridostigmine are able to elicit GH… (More)

Topics

Cite this paper

@article{Obermayr2003TheRR, title={The reduced release of GH by GHRH in 8 subjects aged 65-69 years is augmented considerably by rivastigmine, a drug for Alzheimer's disease.}, author={Rudolf Paul Obermayr and Lothar Mayerhofer and Maarten Knechtelsdorfer and Karl Tragl and Georg Geyer}, journal={Gerontology}, year={2003}, volume={49 3}, pages={191-5} }